312 related articles for article (PubMed ID: 36090777)
1. Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes.
Pellegrini S; Zamarian V; Sordi V
Transpl Int; 2022; 35():10575. PubMed ID: 36090777
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
3. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
[TBL] [Abstract][Full Text] [Related]
4. Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine.
Nostro MC; Keller G
Semin Cell Dev Biol; 2012 Aug; 23(6):701-10. PubMed ID: 22750147
[TBL] [Abstract][Full Text] [Related]
5. Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient.
Han L; He H; Yang Y; Meng Q; Ye F; Chen G; Zhang J
Stem Cells Dev; 2022 Mar; 31(5-6):97-101. PubMed ID: 35018826
[TBL] [Abstract][Full Text] [Related]
6. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
Triolo TM; Bellin MD
Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
[TBL] [Abstract][Full Text] [Related]
8. Pluripotent stem cell-derived pancreatic β-cells: potential for regenerative medicine in diabetes.
Kao DI; Chen S
Regen Med; 2012 Jul; 7(4):583-93. PubMed ID: 22817630
[TBL] [Abstract][Full Text] [Related]
9. How to make insulin-producing pancreatic β cells for diabetes treatment.
Lu J; Xia Q; Zhou Q
Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
[TBL] [Abstract][Full Text] [Related]
10. Converting human pluripotent stem cells into beta-cells: recent advances and future challenges.
Mayhew CN; Wells JM
Curr Opin Organ Transplant; 2010 Feb; 15(1):54-60. PubMed ID: 19855279
[TBL] [Abstract][Full Text] [Related]
11. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
Agrawal A; Narayan G; Gogoi R; Thummer RP
Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
[TBL] [Abstract][Full Text] [Related]
13. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
Cierpka-Kmiec K; Wronska A; Kmiec Z
Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
[TBL] [Abstract][Full Text] [Related]
14. Examining the therapeutic potential of various stem cell sources for differentiation into insulin-producing cells to treat diabetes.
Pan G; Mu Y; Hou L; Liu J
Ann Endocrinol (Paris); 2019 Feb; 80(1):47-53. PubMed ID: 30041820
[TBL] [Abstract][Full Text] [Related]
15. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
[TBL] [Abstract][Full Text] [Related]
16. PDX1
Memon B; Younis I; Abubaker F; Abdelalim EM
Diabetes Metab Res Rev; 2021 Jul; 37(5):e3400. PubMed ID: 32857429
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
Quiskamp N; Bruin JE; Kieffer TJ
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
[TBL] [Abstract][Full Text] [Related]
18. Autologous Pluripotent Stem Cell-Derived β-Like Cells for Diabetes Cellular Therapy.
Millman JR; Pagliuca FW
Diabetes; 2017 May; 66(5):1111-1120. PubMed ID: 28507211
[TBL] [Abstract][Full Text] [Related]
19. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
Bose B; Katikireddy KR; Shenoy PS
Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
[TBL] [Abstract][Full Text] [Related]
20. Selection for CD26
Molakandov K; Berti DA; Beck A; Elhanani O; Walker MD; Soen Y; Yavriyants K; Zimerman M; Volman E; Toledo I; Erukhimovich A; Levy AM; Hasson A; Itskovitz-Eldor J; Chebath J; Revel M
Front Endocrinol (Lausanne); 2021; 12():635405. PubMed ID: 34025576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
